Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research focused on Sarcoidosis and Phenotype, with related work in Etoposide, Genetics, Environmental health. Notable publications include 'Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label,...', 'Phenotypes of organ involvement in sarcoidosis', and 'Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses'.
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
Helsinki by nature: The Nature Step to Respiratory Health
Phenotypes of organ involvement in sarcoidosis
Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels
High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences
A Novel Sarcoidosis Risk Locus for Europeans on Chromosome 11q13.1
Analysis of the prognostic impact of nestin expression in non-small cell lung cancer